The study of feasibility and usefulness of olanzapine for the patients who received oxaliplatin chemotherapy.
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2647713
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Olanzapine; 5mg PO on days 1 to 4 Aprepitant; 125 mg PO on day 1, 80 mg PO on days 2 to 3 5HT3-receptor antagonist; IV administration on day 1 Dexamethasone; 6.6 mg IV on day 1, 4 mg PO on days 2 to 3
Primary outcome(s): The rate of adverse events
Study Design: Single arm Non-randomized
创建时间：
2018-05-15
